Calvin Sjaarda

1.4k total citations
31 papers, 583 citations indexed

About

Calvin Sjaarda is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Calvin Sjaarda has authored 31 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Calvin Sjaarda's work include SARS-CoV-2 and COVID-19 Research (7 papers), Insect and Pesticide Research (6 papers) and Bee Products Chemical Analysis (6 papers). Calvin Sjaarda is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Insect and Pesticide Research (6 papers) and Bee Products Chemical Analysis (6 papers). Calvin Sjaarda collaborates with scholars based in Canada, United States and China. Calvin Sjaarda's co-authors include Katrina Brudzynski, Alan J. Castle, Robert Lannigan, Xudong Liu, Kamal Abubaker, Ping Liang, Henryk Fukś, Linda Kim, Emily R. Hawken and Shi‐Min Yuan and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Calvin Sjaarda

29 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Calvin Sjaarda Canada 12 219 139 103 83 69 31 583
Kathleen M. Schegg United States 20 299 1.4× 418 3.0× 47 0.5× 250 3.0× 64 0.9× 31 1.1k
Antonella Di Palma Italy 14 298 1.4× 65 0.5× 25 0.2× 66 0.8× 104 1.5× 50 616
Mohamad Rima Lebanon 13 267 1.2× 307 2.2× 45 0.4× 222 2.7× 21 0.3× 30 862
Dan Zhou China 13 193 0.9× 304 2.2× 65 0.6× 65 0.8× 157 2.3× 37 566
Yuhua Z. Farnell United States 16 33 0.2× 165 1.2× 85 0.8× 59 0.7× 87 1.3× 39 774
Agnieszka Zabłocka Poland 18 47 0.2× 327 2.4× 36 0.3× 45 0.5× 27 0.4× 53 719
Ulrike Weiler Germany 19 65 0.3× 187 1.3× 184 1.8× 195 2.3× 35 0.5× 40 1.3k
M. J. Estienne United States 23 48 0.2× 135 1.0× 61 0.6× 211 2.5× 78 1.1× 88 1.5k
Pedro Jiménez Mexico 14 67 0.3× 221 1.6× 51 0.5× 50 0.6× 411 6.0× 65 825
Alexandra Shapiro United States 15 244 1.1× 155 1.1× 14 0.1× 125 1.5× 133 1.9× 27 848

Countries citing papers authored by Calvin Sjaarda

Since Specialization
Citations

This map shows the geographic impact of Calvin Sjaarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calvin Sjaarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calvin Sjaarda more than expected).

Fields of papers citing papers by Calvin Sjaarda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calvin Sjaarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calvin Sjaarda. The network helps show where Calvin Sjaarda may publish in the future.

Co-authorship network of co-authors of Calvin Sjaarda

This figure shows the co-authorship network connecting the top 25 collaborators of Calvin Sjaarda. A scholar is included among the top collaborators of Calvin Sjaarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calvin Sjaarda. Calvin Sjaarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sjaarda, Calvin, et al.. (2024). The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics package. Journal of Clinical Virology. 176. 105759–105759. 6 indexed citations
2.
Fattouh, Ramzi, et al.. (2024). Evaluation of 5 Polymerase Chain Reaction Assays for the Detection of Mpox Virus. The Journal of Infectious Diseases. 229(Supplement_2). S156–S162. 1 indexed citations
3.
Noordhof, Curtis, Kathleen Schroeter, Emma Allen‐Vercoe, et al.. (2024). Defined microbial communities and their soluble products protect mice from Clostridioides difficile infection. Communications Biology. 7(1). 135–135. 2 indexed citations
4.
Francis, Magen E., Rachelle Buchanan, Kerry J. Lavender, et al.. (2023). Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2. Nature Communications. 14(1). 5990–5990. 2 indexed citations
5.
6.
Ndishimye, Pacifique, Rachelle Buchanan, Sabin Nsanzimana, et al.. (2023). Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral load. iScience. 26(10). 107959–107959. 3 indexed citations
7.
Sjaarda, Calvin, Lynette Lau, Jared T. Simpson, et al.. (2023). Prevalence of Low-Frequency, Antiviral Resistance Variants in SARS-CoV-2 Isolates in Ontario, Canada, 2020-2023. JAMA Network Open. 6(7). e2324963–e2324963. 5 indexed citations
8.
Bennet, Sean, Martin Kaufmann, Calvin Sjaarda, et al.. (2022). Small-molecule metabolome identifies potential therapeutic targets against COVID-19. Scientific Reports. 12(1). 10029–10029. 9 indexed citations
9.
Isabel, Sandra, Marc R. Isabel, Richard de Borja, et al.. (2022). Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada. Scientific Reports. 12(1). 10867–10867. 10 indexed citations
11.
Sjaarda, Calvin, et al.. (2020). De novo duplication on Chromosome 19 observed in nuclear family displaying neurodevelopmental disorders. Molecular Case Studies. 6(3). a004721–a004721.
12.
Feldman, Maurice A., et al.. (2019). Relationship of family history conditions and early signs of autism spectrum disorder in low and high-risk infants. Research in autism spectrum disorders. 65. 25–33. 5 indexed citations
13.
Sjaarda, Calvin, et al.. (2019). Homozygosity for the 10-repeat dopamine transporter (DAT1) allele is associated with reduced EEG response in males with ASD. Research in autism spectrum disorders. 60. 25–35. 4 indexed citations
14.
Sjaarda, Calvin, Amy J. M. McNaughton, S. Paige Taylor, et al.. (2019). Exome sequencing identifies de novo splicing variant in XRCC6 in sporadic case of autism. Journal of Human Genetics. 65(3). 287–296. 7 indexed citations
15.
Tan, Yue‐Qiu, Chaofeng Tu, Lanlan Meng, et al.. (2017). Loss-of-function mutations in TDRD7 lead to a rare novel syndrome combining congenital cataract and nonobstructive azoospermia in humans. Genetics in Medicine. 21(5). 1209–1217. 81 indexed citations
16.
Sjaarda, Calvin, Patrick Hecht, Amy J. M. McNaughton, et al.. (2017). Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development. Scientific Reports. 7(1). 8735–8735. 32 indexed citations
18.
Brudzynski, Katrina, Calvin Sjaarda, & Robert Lannigan. (2015). MRJP1-containing glycoproteins isolated from honey, a novel antibacterial drug candidate with broad spectrum activity against multi-drug resistant clinical isolates. Frontiers in Microbiology. 6. 711–711. 37 indexed citations
19.
Sjaarda, Calvin, Kamal Abubaker, & Alan J. Castle. (2015). Induction of lcc 2 expression and activity by A garicus bisporus provides defence against T richoderma aggressivum toxic extracts. Microbial Biotechnology. 8(6). 918–929. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026